Ulcerative colitis trials recruiting in North Carolina

All Ulcerative colitis trials nationally

Cities in North Carolina

Recruiting trials in North Carolina

• A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
  NCT07185009 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female) · North Carolina: Fayetteville
• A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
  NCT07113522 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · North Carolina: High Point, Raleigh
• A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
  NCT07196748 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · North Carolina: Chapel Hill, Charlotte
• A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
  NCT05076175 · Phase: Phase 2, Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · North Carolina: Chapel Hill, Charlotte
• A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
  NCT06598943 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · North Carolina: Chapel Hill
• A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
  NCT07012395 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · North Carolina: Chapel Hill, Durham, Winston-Salem
• A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
  NCT05953402 · Phase: Not specified · Ages: No age limits stated · Sex: Female · North Carolina: Wilmington
• A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
  NCT06095128 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · North Carolina: Asheville, Chapel Hill
• A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
  NCT06581328 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · North Carolina: Charlotte, Greenville, Pinehurst, Statesville
• A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
  NCT07654751 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Female · North Carolina: Chapel Hill
• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
  NCT06588855 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female) · North Carolina: Charlotte, Fuquay-Varina, High Point
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
  NCT06979336 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Monroe
• A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
  NCT06975722 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · North Carolina: Chapel Hill
• A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
  NCT06636656 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · North Carolina: Charlotte
• An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
  NCT07184996 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female) · North Carolina: Chapel Hill, Charlotte, Durham, Fayetteville
• An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
  NCT06398626 · Phase: Not specified · Ages: 18 Years to 64 Years · Sex: All (male and female) · North Carolina: Chapel Hill, Charlotte
• BOOM-IBD2 Pivotal Clinical Trial
  NCT06571669 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 85 Years · Sex: All (male and female) · North Carolina: Chapel Hill
• COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)
  NCT07198113 · Phase: Not specified · Ages: 1 Year to 18 Years · Sex: All (male and female) · North Carolina: Chapel Hill, Charlotte, Durham
• Confirmatory Clinical Study in Active Ulcerative Colitis
  NCT07296315 · Phase: Phase 2 · Ages: 16 Years and older · Sex: All (male and female) · North Carolina: Fayetteville, High Point
• IBD Pregnancy Registry
  NCT06910553 · Phase: Not specified · Ages: 18 Years to 50 Years · Sex: Female · North Carolina: Wilmington
• LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
  NCT07415044 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · North Carolina: Greenville, Wilmington
• Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
  NCT06937086 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female) · North Carolina: Fayetteville
• Mirikizumab Real World Protocol
  NCT06696014 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Chapel Hill
• Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
  NCT06750731 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Chapel Hill
• Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
  NCT06619990 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · North Carolina: Raleigh
• Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
  NCT04314375 · Phase: Phase 4 · Ages: 5 Years to 17 Years · Sex: All (male and female) · North Carolina: Greenville
• Zymfentra (Infliximab-dyyb) REal World Cohort STudy
  NCT07237516 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · North Carolina: Chapel Hill, Charlotte, Winston-Salem